̽����ѡ

 started working with CRISPR technology in 2013, shortly after publication of the seminal papers describing CRISPR/Cas9 application in eukaryotic cells. Since then, his work has focused on both CRISPR precision genome engineering and the applications of CRISPR in genetic screening. In 2017, he became Scientific Director and Head of CFG.

 joined CFG in 2019. Previously, she worked as a Lab Manager and Post Doctoral Fellow in the field of DNA repair and cancer, thus bringing in organizational skills and experience as a molecular biologist.

 joined the CFG facility in 2020. She has previous experience as a lab technician in a biochemical lab where she used CRISPR in a myogenic study of the DMD gene.

 joined CFG in 2020. She previously used genome engineering techniques in her postdoctoral research to study transcriptional regulation in cancer. Anneke mainly focuses on precision editing, designing and using different CRISPR modalities such as HDR, base-editing and prime editing to create edited cell lines.

 joined CFG in 2021. With a Master’s degree in Chemistry, a PhD from ̽����ѡ in S. pombe transcriptional regulation, and postdoctoral research in drug discovery, Olga brings a wide range of technologies and expertise to CFG.